An Evidence-Based Approach: M. Officinalis and S. Officinalis for Alzheimer's

By Walsh, Nancy | Clinical Psychiatry News, June 2004 | Go to article overview

An Evidence-Based Approach: M. Officinalis and S. Officinalis for Alzheimer's


Walsh, Nancy, Clinical Psychiatry News


History of Use

Two common herbs of the Labiatae family, Melissa officinalis and Salvia officinalis, have long histories of medicinal use, M. officinalis, or lemon balm, appears in the ancient "Materia Medica" and was much favored by the early English herbalists. "The London Dispensary" (1696) reported that an essence of this plant, drunk in wine, would "strengthen the brain." According to John Gerard's "Herbal" (1633), this plant "comforts the heart, and driveth away all melancholy." A more contemporary voice, Mrs. M. Grieve, wrote in her "Modern Herbal" (1931) that one John Hussey of Sydenham, England, lived to the age of 116 after drinking lemon balm tea for 50 years.

S. officinalis, or common sage, was said by Gerard to be "singular good for the head and braine; it quickneth the senses and memory." Mrs. Grieve described it as "a valuable agent in the delirium of fevers and in the nervous excitement frequently accompanying brain and nervous diseases."

Rationale for Use

A group of researchers from the Medicinal Plant Research Centre, University of Newcastle upon Tyne (England), have identified nicotinic receptor-binding activity in extracts of these plants. They explained, "Brain nicotinic acetylcholine receptors are a family of ligand-gated ion channels, and high-affinity nicotine binding is associated with receptors composed of [[alpha].sub.4][[beta].sub.2] subunits.

The pathogenesis of Alzheimer's disease (AD) includes loss of receptors of this subtype from regions of the brain concerned with cognition and memory ... and the discovery of increasing numbers of agonists and antagonists for this receptor have focused attention on the possibility of nicotinic therapy for AD" (J. Ethnopharmacol. 69[2]:105-14, 2000).

The Randomized Trials

As part of a national project in Iran, Shahin Akhondzadeh, Ph.D., of Tehran University of Medical Sciences, reported on two randomized trials of these herbal extracts in Alzheimer's patients. In an e-mail from Tehran, Dr. Akhondzadeh explained to this newspaper, "Although FDA-approved drugs are in hand for the management of Alzheimer's disease, the outcomes are not fully promising and there is a place for alternative medicine and, in particular, phytotherapy."

He further said that traditional use of these plants has been associated with soothing, carminative, anxiolytic, sedative, and hypnotic effects.

* The M. officinalis study. Eligible patients had a diagnosis of probable Alzheimer's disease and a score of 12 or greater on the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog) and 2 or less on the Clinical Dementia Rating scale (CDR), signifying mild to moderate disease. They were randomized to receive 60 drops of M. officinalis per day or placebo.

A total of 35 patients completed the study. By the end point at week 16, statistically significant differences were seen on both efficacy measures between the active-treatment group and the placebo group: On the ADAS-cog, in which scores range from 0 to 70 with 70 being most severe, changes from baseline were -6.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

An Evidence-Based Approach: M. Officinalis and S. Officinalis for Alzheimer's
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.